levers semaglutide Retatrutide, a triple agonist, delivered 30.3% weight loss at two years in Phase 3. The headlines state: → 70 lbs average loss on 12mg at 80 weeks (28.3% of body weight) → Tirzepatide for Weight Loss -
Description
J.AlbrechtsenN
Body Composition Tracking Shapescale 3D body scans show patients far more than their weight
You guessed it, lactose
It is widely used to treat Type 2 diabetes in adults and off-label for weight loss
The SURMOUNT-1 trial showed 22.5% average weight loss with tirzepatide at 15 mg, compared to 14.9% with semaglutide at 2.4 mg in the STEP-1 trial
In general, symptoms of allergic reaction can be mild or serious
